Recent Regulatory Developments

June 4, 2020
China Publishes Draft Notice on Convergence Matters Related to Transition from MEP Order No. 7 to MEE Order No. 12
May 21, 2020
EPA Releases Proposed Rule Intended to Improve the Transparency of Guidance
May 18, 2020
Final SECURE Rule Will Update and Modernize USDA’s Biotechnology Regulations
May 15, 2020
Find B&C’s Updates And Analysis Of Chemical Regulatory Impacts Of COVID-19 In One Place
May 8, 2020
China Publishes Long-Awaited Revised MEP Order No. 7
May 7, 2020
GAO Priority Recommendations for EPA Include Assessing and Controlling Toxic Chemicals
April 28, 2020
EPA Publishes Draft Risk Evaluation of Perchloroethylene
April 27, 2020
B&C Frequently Asked Questions (FAQ) on TSCA Fees for EPA-Initiated Risk Evaluations, Preliminary Lists for 20 High-Priority Chemicals, and Self-Identification Requirements
April 21, 2020
FDA Issues Emergency Authorized Use for Manufacturers of Face Masks
April 21, 2020
EPA Releases Second Set of Draft Scope Documents for Remaining High-Priority Substances
 1 2 3 >  Last › View 10 | 25 | 50 | 100 per page
 
BERGESON & CAMPBELL, P.C.
2200 Pennsylvania Avenue, NW, Suite 100W
Washington, D.C. 20037
202-557-3800 • 202-557-3836 (fax) | lawbc.com
Contact • Twitter
 
Privacy Policy | Terms of Use | Cookie Policy | Attorney Advertising | Trademarks
©2020 Bergeson & Campbell, P.C.
All Rights Reserved.

We are very pleased to offer complimentary subscription to our informative newsletter(s), but we will need to collect some information to do so.

Please carefully read the provisions of the PRIVACY POLICY and the TERMS OF SERVICE ( click to read )

When you opt-in by clicking the button below, you agree to share your USER ID, EMAIL ADDRESS, COMPANY AFFILIATION, and JOB TITLE for the purpose of receiving our emailed newsletter(s).

If you do not accept these terms of use, do not subscribe to our newsletter(s).




I agree to the collection and use of my personal data as described above.


I do not agree to the collection and use of my personal data as described above and therefore agree not to access this subscription form.